Milestone Pharmaceuticals (MIST)

• Market cap: $154M
• 1 day: -2.36%
• 5 days: -4.62%
• 1 month: -3.88%
• 3 months: -40.67%
• 6 months: -39.51%
• Year to date: -39.51%
• 1 year: -25.75%
• 5 years: -77.08%
• 10 years: -91.93%
• Sector: Healthcare
• Industry: Biotechnology

About: Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.

Employees: 38